GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

Home・Список акций・BioArctic AB

B
BioArctic AB

Закрыт

284.6 -2.47

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

284.2

Макс.

285.2

Ключевые показатели
By Trading Economics
Доход	-896M 179M
Продажи	-897M 392M
P/E Средняя по отрасли	23.701 35.69
Прибыль на акцию	1.09
Рентабельность продаж	45.668
Сотрудники	119
EBITDA	-893M 188M

Рыночная статистика
By TradingEconomics
Рыночная капитализация	4.5B 25B
Предыдущая цена открытия	287.07
Предыдущая цена закрытия	284.6

BioArctic AB График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

26 сент. 2025 г., 18:25 UTC

Главные движущие силы рынка

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

27 сент. 2025 г., 07:00 UTC

Отчет

This Water Stock Is Dehydrated. What Could Bring It Back. -- Barrons.com

27 сент. 2025 г., 04:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

26 сент. 2025 г., 21:56 UTC

Приобретения, слияния, поглощения

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

26 сент. 2025 г., 20:54 UTC

Отчет

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

26 сент. 2025 г., 20:50 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

26 сент. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

26 сент. 2025 г., 20:27 UTC

Приобретения, слияния, поглощения

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 сент. 2025 г., 20:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

26 сент. 2025 г., 19:54 UTC

Обсуждения рынка

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

26 сент. 2025 г., 19:53 UTC

Приобретения, слияния, поглощения

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 сент. 2025 г., 19:40 UTC

Отчет

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

26 сент. 2025 г., 19:24 UTC

Обсуждения рынка

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

26 сент. 2025 г., 19:17 UTC

Обсуждения рынка

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

26 сент. 2025 г., 19:15 UTC

Обсуждения рынка

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

26 сент. 2025 г., 19:03 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

26 сент. 2025 г., 19:03 UTC

Обсуждения рынка

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

26 сент. 2025 г., 18:50 UTC

Обсуждения рынка

Отчет

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

26 сент. 2025 г., 18:36 UTC

Обсуждения рынка

Silver Closes Out Week With Strong Surge -- Market Talk

26 сент. 2025 г., 18:02 UTC

Приобретения, слияния, поглощения

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

26 сент. 2025 г., 18:02 UTC

Приобретения, слияния, поглощения

ING: Global Development Hasn't Received All Necessary Approvals >ING

26 сент. 2025 г., 18:02 UTC

Приобретения, слияния, поглощения

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

26 сент. 2025 г., 17:54 UTC

Обсуждения рынка

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

26 сент. 2025 г., 16:56 UTC

Обсуждения рынка

Отчет

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

26 сент. 2025 г., 16:41 UTC

Обсуждения рынка

Отчет

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

26 сент. 2025 г., 16:26 UTC

Отчет

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

26 сент. 2025 г., 16:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

26 сент. 2025 г., 16:12 UTC

Обсуждения рынка

Nike Stock Seen With Limited Upside -- Market Talk

26 сент. 2025 г., 15:59 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

26 сент. 2025 г., 15:59 UTC

Обсуждения рынка

Nike Seen Showing Progress in Turnaround -- Market Talk

Сравнение c конкурентами

Изменение цены

BioArctic AB Прогноз

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.